Nephrol Dial Transplant (2001) 16: 1986-1991
© 2001 European Renal Association-European Dialysis and Transplant Association
Controversy
Impact of contaminated dialysate on long-term haemodialysis-related complications: is it really that important?
1 Department of Haemodialysis and Nephrology, Medical Centre Alkmaar, Wilhelminalaan, Alkmaar and 2 Department of Nephrology, Academisch Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands
Introduction
Recently, in haemodialysis (HD) concern has been raised about the long-term consequences of non-sterile dialysate and the concomitant use of dialysers with large pore size, usually high-flux devices [1,2]. According to current opinion, monocytes are activated by the repeated transfer of bacteria-derived substances from the dialysate compartment to the circulation of the patient, resulting in the secretion of a variety of pro-inflammatory cytokines, such as interleukin-1ß (IL-1ß), interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF
). Due to the recurrent character of the stimulus, a chronic inflammatory state is induced, leading to a number of long-term HD-related complications, such as infections, malnutrition, dialysis-related amyloidosis (DRA), accelerated atherosclerosis and increased mortality [3].
However, the cause and nature of HD-induced monocyte activation is a controversial issue. Various provoking factors have been recognized, including complement activation [4], coagulation [5], mechanical stress and shear
Monocyte activation in experimental closed-loop circuits
Clinical evidence of transfer across haemodialysis membranes
Antibodies against endotoxins
LAL activity in the blood
Intra- and peri-dialytical studies
Follow-up studies: clinical parameters
Conclusions
Editor's note
Notes
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. M. Lamas, M. Alonso, F. Sastre, G. Garcia-Trio, J. Saavedra, and L. Palomares Ultrapure dialysate and inflammatory response in haemodialysis evaluated by darbepoetin requirements--a randomized study Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2851 - 2858. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. C. Grooteman and M. J. Nube Impact of the type of dialyser on the clinical outcome in chronic haemodialysis patients: does it really matter? Nephrol. Dial. Transplant., December 1, 2004; 19(12): 2965 - 2970. [Full Text] [PDF] |
||||
